Endostar acts as a pneumonitis protectant in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiotherapy

Endostar acts as a pneumonitis protectant in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiotherapy

Abstract Background CCRT is presently the standard treatment for LA-NSCLC. RP is one of the main obstacles to the completion of thoracic radiation therapy, resulting in limited survival benefits in NSCLC patients. This research aims to explore the role of Endostar in the occurrence of grade≥2 RP and...

Full description

Bibliographic Details
Main Authors: Kuifei Chen, Shuling Li, Meng Chen, Zhicheng Jin, Xuefeng Sun, Suna Zhou, Haihua Yang
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Cancer
Subjects:
Endostar
Radiation pneumonitis
Concurrent chemoradiotherapy
Locally advanced non-small cell lung cancer
Online Access:https://doi.org/10.1186/s12885-024-12001-6

Internet

https://doi.org/10.1186/s12885-024-12001-6

Similar Items